Press release
Global Chronic Obstructive Pulmonary Disease Drugs Market to reach USD 27.28 Bn at a CAGR of 5.1 percent by 2030- Says Stellar Market Research
Chronic Obstructive Pulmonary Disease Drugs Market
To Get Further Details, Click This Link:https://www.stellarmr.com/report/req_sample/chronic-obstructive-pulmonary-disease-drugs-market/2379
Chronic Obstructive Pulmonary Disease Drugs Market Report Scope and Research Methodology
Market Size in 2023: USD 19.26 Billion
Market Size in 2030: USD 27.28 Billion
CAGR: 5.1 Percent
Forecast Period: 2024-2030
Base Year: 2023
Number of Pages: 212
No. of Tables: 163
No. of Charts and Figures: 114
Segment Covered: By COPD Type, Drug Class, Administration Type, and Distribution Channel.
Regional Scope: North America, Europe, Asia Pacific, and Africa, South America
Report Coverage: Market Share, Size and Forecast by Revenue | 2023-2030, Market Dynamics, Growth Drivers, Restraints, Investment Opportunities, and Key Trends, Competitive Landscape, Key Players Benchmarking, Competitive Analysis, MMR Competition Matrix, Competitive Leadership Mapping, Global Key Players' Market Ranking Analysis.
Global Chronic Obstructive Pulmonary Disease Drugs Market Dynamics
The major growth driver behind the global Chronic Obstructive Pulmonary Disease (COPD) drugs market is the rising prevalence of COPD, fuelled by factors such as smoking, air pollution, and aging populations. Enhanced awareness and early diagnosis are also contributing, as they lead to increased demand for effective treatments. Additionally, advancements in drug development, particularly combination therapies and innovative treatments, are driving market expansion by improving patient outcomes and reducing exacerbations.
To Get Further Details, Click This Link:https://www.stellarmr.com/report/req_sample/chronic-obstructive-pulmonary-disease-drugs-market/2379
Global Chronic Obstructive Pulmonary Disease Drugs Market Regional Insights
In 2023, North America led the global COPD drugs market due to advanced healthcare infrastructure, high prevalence, and significant pharmaceutical investments. Europe followed, benefiting from a sophisticated healthcare system and proactive disease management. The Asia-Pacific region showed the fastest growth, driven by rising COPD rates and expanding healthcare access. Latin America and the Middle East & Africa also saw growth, though they faced challenges like limited infrastructure and healthcare access.
Global Chronic Obstructive Pulmonary Disease Drugs Market Segmentation
By COPD Type
Chronic Bronchitis
Emphysema
By Drug Class
Combination Therapy
Bronchodilators
Corticosteroids
Phosphodiesterase Type 4 Inhibitor
Mucokinetics
Others
By Administration Type
Inhalation Devices
Oral Medications
Injectable Formulations
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Chronic Obstructive Pulmonary Disease Drugs Market Key Competitors include:
Pfizer Inc. (United States)
Abbott Laboratories (United States)
Vertex Pharmaceuticals (United States)
GlaxoSmithKline (United Kingdom)
AstraZeneca (United Kingdom)
Boehringer Ingelheim (Germany)
Novartis AG (Switzerland)
Chiesi Farmaceutici S.p.A. (Italy)
F. Hoffmann-La Roche Ltd. (Switzerland)
Sanofi (France)
Almirall (Spain)
Orion Corporation (Finland)
Sun Pharmaceutical Industries Ltd. (India)
Cipla Limited (India)
Daiichi Sankyo Company, Limited (Japan)
Zydus Cadila (India)
Takeda Pharmaceutical Company Limited (Japan)
Eurofarma Laboratórios S.A. (Brazil)
Grupo Ferrer Internacional S.A. (Spain)
Laboratorio Elea S.A.C.I.F. y A. (Argentina)
Genomma Lab Internacional S.A.B. de C.V. (Mexico)
For more information about this report visit the Report :https://www.stellarmr.com/report/chronic-obstructive-pulmonary-disease-drugs-market/2379
Key questions answered in the Global Chronic Obstructive Pulmonary Disease Drugs Market are:
What is Chronic Obstructive Pulmonary Disease?
What is the current growth rate of the Global Chronic Obstructive Pulmonary Disease Drugs Market?
Who are the key players in the Global Chronic Obstructive Pulmonary Disease Drugs Market?
What are the factors affecting growth in the Global Chronic Obstructive Pulmonary Disease Drugs Market?
Who held the largest market share in the Global Chronic Obstructive Pulmonary Disease Drugs Market?
What is the demand pattern for the Global Chronic Obstructive Pulmonary Disease Drugs Market?
What are the opportunities for the Global Chronic Obstructive Pulmonary Disease Drugs Market?
What are the strategies used by competitors in the Global Chronic Obstructive Pulmonary Disease Drugs Market?
What are the growth prospects in developing countries for the Global Chronic Obstructive Pulmonary Disease Drugs Market?
Which segment is expected to witness the fastest growth and why in the Global Chronic Obstructive Pulmonary Disease Drugs Market?
Key Offerings:
Past Market Size and Competitive Landscape (2018 to 2022)
Past Pricing and price curve by region (2018 to 2022)
Market Size, Share, Size & Forecast by Different Segment | 2024-2030
Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by Region
Market Segmentation - A detailed analysis by Intervention, Product, Diseases, Distribution Channels, and Region
Competitive Landscape - Profiles of selected key players by region in a strategic perspective
Competitive landscape - Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER's analysis
Value chain and supply chain analysis
Legal Aspects of business by region
Lucrative business opportunities with SWOT analysis
Recommendations
Stellar Market Research is leading Chemical & Material research firm, has also published the following reports:
Global Gluconic Acid Market size was valued at USD 181.54 Mn. in 2023 and is expected to reach USD 231.60 Mn. by 2030, at a CAGR of 3.54%.
The Isopropyl Myristate Market size was valued at USD 71.32 Mn. in 2023 and the total Isopropyl Myristate Market size is expected to grow at a CAGR of 7.67% from 2024 to 2030, reaching nearly USD 119.64 Mn. by 2030.
Contact STELLAR MARKET RESEARCH PVT. LTD.
S.no.8, h.no. 4-8 Pl.7/4, Kothrud,
Pinnac Memories Fl. No. 3, Kothrud, Pune,
Pune, Maharashtra, 411029
mailto:sales@stellarmr.com
About Stellar Market Research:
Stellar Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Chronic Obstructive Pulmonary Disease Drugs Market to reach USD 27.28 Bn at a CAGR of 5.1 percent by 2030- Says Stellar Market Research here
News-ID: 3629847 • Views: …
More Releases from STELLAR MARKET RESEARCH
Ready to Eat (RTE) Baked Products and Bakery Premixes Market Share, Industry Gro …
Ready to Eat (RTE) Baked Products and Bakery Premixes Market was estimated at USD 154.85 Bn. in 2024 and the total revenue is projected to grow at CAGR of 7% From 2025 to 2032 reaching nearly USD 231.41 Bn. by 2032.
Stellar Market Research published a report "Ready to Eat Baked Products and Bakery Premixes Market and forecast (2025-2032)." The report is a comprehensive analysis of global Ready to Eat Baked…
Micromotor Market Comprehensive Research Study, Competitive Landscape and Foreca …
Micromotor Market was estimated at USD 43.10 Bn in 2024, and its total revenue is projected to grow at a CAGR of 7.1% from 2025 to 2032, reaching nearly USD 69.66 Bn by 2032.
Stellar Market Research published a report "Micromotor Market and forecast (2025-2032)." The report is a comprehensive analysis of global Micromotor Market share, size, growth, trends, and forecast. The report also contains competitor analysis and regional analysis and…
Monkeypox Vaccine and Treatment Market Sales and Revenues of Manufacturers Forec …
Monkeypox Vaccine and Treatment Market size was estimated at USD 103.5 Mn in 2024 and the total Global Monkeypox Vaccine and Treatment revenue is projected to grow at a CAGR of 10.20% from 2025 to 2032, reaching nearly USD 225.12 Mn by 2032.
Stellar Market Research published a report "Monkey pox Vaccine and Treatment Market and forecast (2025-2032)." The report is a comprehensive analysis of global monkey pox Vaccine and Treatment…
K12 Education Market Dynamics, Competitive Landscape, Outlook 2025-2032
K12 Education Market Size was valued at USD 2.65 Tn in 2024 and is projected to grow at a CAGR of 12.6% from 2025 to 2032, reaching nearly USD 6.85 Tn by 2032.
Stellar Market Research has released a report "K12 Education Market and forecast (2025-2032)." The report is a detailed analysis of the global market share, size, growth, trends, and forecast of K12 Education Market. It also includes competitor and…
More Releases for Chronic
Chronic Pain Treatment Market - Relieving Chronic Pain: Discover the Latest Inno …
Newark, New Castle, USA: The "Chronic Pain Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Chronic Pain Treatment Market: https://www.growthplusreports.com/report/chronic-pain-treatment-market/8030
This latest report researches the industry structure,…
Refractory Chronic Cough Therapeutics Market - Silencing the Cough: Innovative T …
Newark, New Castle, USA: The "Refractory Chronic Cough Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Refractory Chronic Cough Therapeutics Market: https://www.growthplusreports.com/report/refractory-chronic-cough-therapeutics-market/7991
This latest report researches the…
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers…
Chronic Hepatitis Therapeutics Market - Empowering Liver Health, Defying Chronic …
Newark, New Castle, USA - new report, titled Chronic Hepatitis Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Hepatitis Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Hepatitis Therapeutics market. The report offers an overview of…
Chronic Phase Chronic Myeloid Leukemia Market to Witness Growth by 2032, Estimat …
DelveInsight's "Chronic Phase Chronic Myeloid Leukemia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Chronic Phase Chronic Myeloid Leukemia , historical and forecasted epidemiology as well as the Chronic Phase Chronic Myeloid Leukemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Chronic Phase Chronic Myeloid Leukemia market report provides current treatment practices, emerging drugs, the market share…
Boot chronic pain
For immediate release
Due to our rushed lives and stressful environment, many people are suffering from chronic pain and fatigue.
We feel permanently tired and are barely able to get through our normal day. One is able to change this status when following the guidelines the book "Tired of being Tired to the point of being Gatvol (Fed Up). Some people will need a team of medical practitioners to help them…
